1,7-phenanthroline has been researched along with Alloxan Diabetes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, X; Chu, K; Huang, M; Lai, X; Lu, J; Wang, Y; Wu, S; Xie, Y | 1 |
| Cool, DR; Elased, KM; Morris, M | 1 |
| Chan, KK; Cheng, CH; Lee, KW; Leung, AW; Leung, KS; Yue, KK | 1 |
| Sakurai, H; Tsuji, A | 1 |
| Brand, RM; Hamel, FG | 1 |
| Boschero, AC; de Lúcio, MA; Eizirik, DL; Hoffmann, ME | 1 |
6 other study(ies) available for 1,7-phenanthroline and Alloxan Diabetes
| Article | Year |
|---|---|
Antidiabetic effect of the total polyphenolic acids fraction from Salvia miltiorrhiza Bunge in diabetic rats.
Topics: Acids; Administration, Oral; Animals; Blood Glucose; Blood Urea Nitrogen; Diabetes Mellitus, Experimental; Diet, High-Fat; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Phenanthrolines; Polyphenols; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Streptozocin | 2012 |
Novel mass spectrometric methods for evaluation of plasma angiotensin converting enzyme 1 and renin activity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Captopril; Chelating Agents; Diabetes Mellitus, Experimental; Edetic Acid; Male; Mice; Mice, Knockout; Peptidyl-Dipeptidase A; Phenanthrolines; Receptor, Angiotensin, Type 1; Renin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2005 |
Danshen prevents the occurrence of oxidative stress in the eye and aorta of diabetic rats without affecting the hyperglycemic state.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aorta, Thoracic; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Eye; Glutathione; Hyperglycemia; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Phenanthrolines; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Streptozocin | 2006 |
Generation of nitric oxide from streptozotocin (STZ) in the presence of copper(II) plus ascorbate: implication for the development of STZ-induced diabetes.
Topics: Animals; Ascorbic Acid; Chelating Agents; Copper; Diabetes Mellitus, Experimental; Disease Models, Animal; Edetic Acid; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Hemin; Hypoglycemic Agents; Islets of Langerhans; Niacinamide; Nitric Oxide; Phenanthrolines; Rats; Spectrophotometry; Streptozocin | 1998 |
Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic rats.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diffusion; Iontophoresis; Male; Organometallic Compounds; Phenanthrolines; Rats; Rats, Sprague-Dawley; Skin Absorption; Time Factors | 1999 |
1,10 phenanthroline, a metal chelator, protects against alloxan- but not streptozotocin-induced diabetes.
Topics: Alloxan; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Hydroxides; Hydroxyl Radical; Iron Chelating Agents; Male; Methylurea Compounds; Phenanthrolines; Rats; Rats, Inbred Strains; Streptozocin | 1986 |